Norwegian National Advisory Unit on Prehospital Emergency Medicine, Oslo University Hospital, Oslo, Norway; Department of Oncology, Oslo University Hospital, Oslo, Norway.
Department of Biostatistics and Epidemiology, Oslo University Hospital, Oslo, Norway.
Resuscitation. 2019 Mar;136:112-118. doi: 10.1016/j.resuscitation.2019.01.020. Epub 2019 Jan 29.
Guidelines recommend constant or escalating energy levels for shocks after the initial defibrillation attempt. Studies comparing survival to hospital discharge with escalating vs fixed high energy level shocks are lacking. We compared survival to hospital discharge for 200 J escalating to 360 J vs fixed 360 J in patients with initial ventricular fibrillation/pulseless ventricular tachycardia in a post-hoc analysis of the Circulation Improving Resuscitation Care trial database.
Pre-shock rhythm, rhythm 5 s after shock, shock energy levels, termination of ventricular fibrillation/pulseless ventricular tachycardia (TOF), and survival to hospital discharge were recorded. Association between defibrillation strategy and survival to hospital discharge was investigated with multivariable logistic regression. The escalating energy group included 260 patients and 883 shocks vs 478 patients and 1736 shocks in the fixed-high energy group. There was no difference in survival to hospital discharge between escalating (70/255 patients, 28%) and fixed energy group (132/478 patients, 28%) (unadjusted OR 1.00, 95% CI 0.72-1.42 and adjusted OR 0.81, 95% CI 0.54-1.22, p = 0.32). First shock TOF was 86% in the escalating group compared to 83% in the fixed-high group, p = 0.27.
There was no difference in survival to hospital discharge or the frequency of TOF between escalating energy and fixed-high energy group. ClinicalTrials.gov Identifier: NCT00597207.
指南建议在初始除颤尝试后保持或增加电击能量。缺乏比较递增与固定高能级电击与存活率至出院的研究。我们在Circulation Improving Resuscitation Care 试验数据库的事后分析中比较了初始心室颤动/无脉性室性心动过速患者中 200J 递增至 360J 与固定 360J 的存活率至出院。
记录了预电击节律、电击后 5 秒的节律、电击能量水平、心室颤动/无脉性室性心动过速终止(TOF)和存活率至出院。使用多变量逻辑回归研究了除颤策略与存活率至出院的关系。递增能量组包括 260 例患者和 883 次电击,固定高能量组包括 478 例患者和 1736 次电击。递增能量组(70/255 例患者,28%)与固定高能组(132/478 例患者,28%)的存活率至出院无差异(未调整的 OR 1.00,95%CI 0.72-1.42 和调整后的 OR 0.81,95%CI 0.54-1.22,p=0.32)。递增组的首次电击 TOF 为 86%,而固定高组为 83%,p=0.27。
在存活率至出院或 TOF 频率方面,递增能量组与固定高能级组之间无差异。临床试验.gov 标识符:NCT00597207。